PASG
PASG
NASDAQ · Biotechnology

Passage Bio Inc

$9.51
+0.40 (+4.39%)
As of Feb 8, 2:22 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.14M 4.29M 4.24M
Net Income -270,468 -254,054 -270,426
EPS
Profit Margin -6.5% -5.9% -6.4%
Rev Growth -4.9% +3.8% -2.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.81M 1.85M 2.19M
Total Equity 14.22M 12.92M 13.95M
D/E Ratio 0.13 0.14 0.16
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -483,031 -431,767 -494,923
Free Cash Flow -204,723 -222,413 -294,472